Literature DB >> 11308180

Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5.

E P Chen1, H B Bittner, S A Akhter, W J Koch, R D Davis.   

Abstract

BACKGROUND: Chronic heart failure is associated with impairment of the myocardial beta-adrenergic receptor (beta-AR) system. In this study, the effects of G protein-coupled receptor kinase 5 (GRK5) overexpression on myocardial performance were directly assessed in the hearts of transgenic mice using an isolated work-performing murine heart preparation and computerized analysis of functional data.
METHODS: A controlled experimental study was performed to evaluate cardiac function in both transgenic mice with a 30-fold overexpression of GRK5 (n = 9, 23 to 29 g) and littermate controls (n = 10, 22 to 29 g). Preload-dependent cardiac output, contractility, stroke work, stroke volume, and heart rate were compared between the two groups.
RESULTS: Significant decreases in preload-dependent cardiac output and contractility were observed in the mice with GRK5 overexpression when compared with control group mice and occurred in association with significant decreases in stroke work and stroke volume. There was no significant difference in the average heart rate between the two groups.
CONCLUSIONS: These data suggest that GRK5 upregulation may be partially responsible for alterations in myocardial function in chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308180     DOI: 10.1016/s0003-4975(00)01754-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

Review 1.  Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Mol Pharmacol       Date:  2009-06-02       Impact factor: 4.436

Review 2.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

3.  Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor.

Authors:  Kristoff T Homan; Helen V Waldschmidt; Alisa Glukhova; Alessandro Cannavo; Jianliang Song; Joseph Y Cheung; Walter J Koch; Scott D Larsen; John J G Tesmer
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

Review 4.  G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling.

Authors:  Michael D Steury; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Immunol       Date:  2017-06-10       Impact factor: 3.543

5.  Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure.

Authors:  Yan Zhang; Scot J Matkovich; Xiujun Duan; Jessica I Gold; Walter J Koch; Gerald W Dorn
Journal:  Circ Heart Fail       Date:  2011-07-18       Impact factor: 8.790

6.  A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.

Authors:  Stephen B Liggett; Sharon Cresci; Reagan J Kelly; Faisal M Syed; Scot J Matkovich; Harvey S Hahn; Abhinav Diwan; Jeffrey S Martini; Li Sparks; Rohan R Parekh; John A Spertus; Walter J Koch; Sharon L R Kardia; Gerald W Dorn
Journal:  Nat Med       Date:  2008-04-20       Impact factor: 53.440

7.  Overlapping and opposing functions of G protein-coupled receptor kinase 2 (GRK2) and GRK5 during heart development.

Authors:  Melanie Philipp; Ina M Berger; Steffen Just; Marc G Caron
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

8.  G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.

Authors:  Philip W Raake; Leif E Vinge; Erhe Gao; Matthieu Boucher; Giuseppe Rengo; Xiongwen Chen; Brent R DeGeorge; Scot Matkovich; Steven R Houser; Patrick Most; Andrea D Eckhart; Gerald W Dorn; Walter J Koch
Journal:  Circ Res       Date:  2008-07-17       Impact factor: 17.367

Review 9.  Proinflammatory Cytokines Mediate GPCR Dysfunction.

Authors:  Maradumane L Mohan; Neelakantan T Vasudevan; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2017-08       Impact factor: 3.105

10.  Grk5l controls heart development by limiting mTOR signaling during symmetry breaking.

Authors:  Martin D Burkhalter; Gregory B Fralish; Richard T Premont; Marc G Caron; Melanie Philipp
Journal:  Cell Rep       Date:  2013-08-22       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.